Skip to main content
. 2021 Nov 6;2021(11):CD001800. doi: 10.1002/14651858.CD001800.pub4

Roman 1983.

Study characteristics
Methods Study design: single‐centre RCT
Country: Chile
Dates participants recruited: June 1973 to June 1981
Maximum follow‐up: 9 years
Participants Inclusion criteria: participants with transmural AMI
Exclusion criteria: severe arrhythmias persisting after the acute phase of AMI (frequent ventricular premature beats, grade iii‐iv of the Lown classification, atrial flutter, partial or complete AV block); great left‐ventricular enlargement; left ventricular aneurysm; persistent cardiac failure; severe diastolic hypertension post‐myocardial infarction angina.
N randomised: total: 193; intervention: 93; comparator: 100
Diagnosis (% of participants):
Transmural AMI: 100%
Anterior wall infarction: 55%
Posteroinferior infarction: 45%
Age (mean ± SD): intervention: 56.2 ± 10.3; comparator: 59.1 ± 8.8
Percentage male: intervention: 93.6%; comparator: 87%
Ethnicity: NR
Interventions Intervention: Supervised physical training programme according to the guidelines reported by Zohman and Tobias. It was started with combined ergometric, callisthenic and walk‐jogging exercise lasting 30 min, three times a week. The intensity of the training was graded according to the target heart rate threshold, defined as 70% of maximal heart rate achieved by the participant in the former ergometric work test.
Components: exercise only
Setting: centre
Exercise programme modality: combined ergometric and walk‐jogging exercise
Length of session: 30 min
Frequency: three times a week
Intensity: 70% of maximal heart rate
Resistance training included? Callisthenics
Total duration: average 42 months (range 6 to 108 months)
Co‐interventions: none described
Comparator: Control participants were medically treated according to the guidelines commonly used; namely, short‐ and long‐lasting nitrites, ß‐ blockers or Ca antagonists (nifedipine).
Co‐interventions: A small number (8 participants) were also treated with oral anticoagulants.
Outcomes Mortality, MI and revascularisations
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk “Patients were randomly allocated…”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes Low risk 18/93 (19.4%) and 18/100 (18%) withdrew or dropped out from intervention and control groups over the 9‐year period.
Selective reporting (reporting bias) Low risk Mortality, morbidity and complications were recorded over the duration of the study and are presented as rates.